Optimal Clinical Trials ads

Attending the BIO International Convention from 22–25 June and planning an upcoming early or late phase study? Catch up with our team from Australasia’s largest all-phase clinical trials group and discover how New Zealand Clinical Research (NZCR), Optimal Clinical Trials, and our wider network of around 1,000 research professionals can deliver high quality results at speed and scale for your next study. To arrange a meeting, please send a request through the partnering system or visit the New Zealand Pavilion to connect with Dr Christian Schwabe, Shawnna Barrett, Lucia Druzianic, Amanda Karunaratne, and Aakanksha Deshwal. We look forward to seeing you there. For more info, please email [email protected]

Going to ARCS Australia Annual Conference 2026? Our CEO, Dr Liz Smaill, Senior Business Development Manager Aakanksha Deshwal, and Dr Christian Schwabe, NZCR Group Executive Director and Senior Research Physician, will be there representing the NZCR Group, Australia and New Zealand's largest all-phase clinical trials network. They'd love to discuss how our group can deliver high quality results at speed and scale for your upcoming early or late phase studies, and hear perspectives from across the sector on the future of healthcare and clinical research. Visit us at the New Zealand Pavilion or email [email protected] to arrange a time to meet.

Aakanksha Deshwal has joined Optimal Clinical Trials as Senior Business Development Manager and will be working closely with our CEO, Dr Liz Smaill. Together, they will focus on further strengthening how we support CROs and study sponsors in delivering late phase studies across New Zealand with the speed and scale that our team at Optimal is now known for. Aakanksha brings CRO experience where she worked across business development and study implementation, supporting global and large-volume clinical trials. Her experience spans feasibility strategy, proposal development, and sponsor engagement - aligning study requirements with site capability, timelines, and delivery. Many of you will already know Liz. Since joining Optimal in 2016 and now leading the business as CEO, she has helped define who we are - bringing together purpose, people, and performance to ensure Optimal continues to deliver research that truly makes a difference. Our team is ready to support you to get your upcoming studies started and keep them moving forward. Feel free to reach out on [email protected]

Say hello to our team at the The World Vaccine Congress - Dr Liz Smaill (Optimal), Dr Barney Montgomery (Optimal, experienced PI), and Karl Ramsden (Fusion). They look forward to catching up with you at Booth 449 and supporting your upcoming vaccine studies with speed and scale. Book here to chat with our team: https://lnkd.in/gmKD3eVm You’re also invited to join our presentation “A Standout Advantage: High quality results delivered at speed and scale” on Wed 1 Apr, 3:10 PM Rm 204AB Level 2. Click here: https://lnkd.in/emj2nWP8

Looking for an advantage? Need Speed and Scale? If you’re at The World Vaccine Congress, you’re invited to join our presentation on Wed 1, Apr 3:10 PM Room 204AB Level 2 “A Standout Advantage: High quality results delivered at speed and scale”. Dr Liz Smaill and Karl Ramsden will show how Australasia’s late phase clinical trial leaders, Optimal Clinical Trials and Fusion Clinical Research work together to deliver rapid startup and high recruitment for your vaccine studies across Australia and New Zealand. Click here: https://lnkd.in/emj2nWP8 You can also click the link to book a time to chat with Dr Liz Smaill (Optimal), Dr Barney Montgomery (Optimal, experienced PI), and Karl Ramsden (Fusion): https://lnkd.in/gmKD3eVm We look forward to catching up with you at Booth 449 and supporting your upcoming vaccine studies.

Our NPS of 100 from sponsors and monitors means a great deal to us. It reflects the consistent high standards our team brings to every study. Thank you to our sponsors for trusting us to support them in the development of new, safer, or better treatments. And to our team for the care and commitment that makes feedback like this possible. “Emma Goodes and Michelle Recana have been exceptional as the coordinators on this study. The source documentation is well organised and up to date, my requests are always answered in a timely manner, and they maintain a positive attitude with a challenging study. I am grateful to be working with them both alongside the rest of the Optimal team on this study.” - CRA #ResearchForGood #OptimalClinicalTrials #ClinicalTrials #Research